The Valley Desk

NCT03598608 · Interventional trial

Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov